Supernus Pharmaceuticals Says Onapgo Approved by FDA for Parkinson's Disease-February 2024-www.financetom.com

Supernus Pharmaceuticals Says Onapgo Approved by FDA for Parkinson's Disease

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Supernus Pharmaceuticals Says Onapgo Approved by FDA for Parkinson's Disease

Feb 4, 2025 7:03 AM

09:33 AM EST, 02/04/2025 (MT Newswires) -- Supernus Pharmaceuticals ( SUPN ) said Tuesday that the US Food and Drug Administration has approved its Onapgo injection to treat motor fluctuations in adults with advanced Parkinson's disease.

The biopharmaceutical company said Onapgo will be available in Q2.

Shares of Supernus Pharmaceuticals ( SUPN ) were up more than 4% in early trading.

Previous page： --Street Color: Core Scientific Terminates Merger Deal With CoreWeave Next page： Core Scientific shareholders reject $9 billion CoreWeave offer, deal terminated

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

--Street Color: Core Scientific Terminates Merger Deal With CoreWeave

Oct 30, 2025

10:38 AM EDT, 10/30/2025 (MT Newswires) -- Price: 20.35, Change: -0.43, Percent Change: -2.05 ...

Core Scientific shareholders reject $9 billion CoreWeave offer, deal terminated

Oct 30, 2025

(Reuters) -Crypto miner Core Scientific ( CORZ ) on Thursday ended a deal for its sale to CoreWeave ( CRWV ) after shareholders voted against the proposal, marking the culmination of months-long investor and proxy campaigns against the agreement. The move marks the second foiled attempt by CoreWeave ( CRWV ) to scoop up Core Scientific ( CORZ ), with...

Core Scientific Terminates Merger Agreement With CoreWeave

Oct 30, 2025

10:37 AM EDT, 10/30/2025 (MT Newswires) -- Core Scientific ( CORZ ) said Thursday it has terminated its merger agreement with CoreWeave ( CRWV ) because it didn't receive the necessary votes from shareholders. Core Scientific ( CORZ ) will continue trading on the Nasdaq Composite, it said. CoreWeave ( CRWV ) did not immediately reply to a request for...

Boeing's Financial Outlook Constrained for the Coming Years, Deutsche Bank Says

Oct 30, 2025

10:39 AM EDT, 10/30/2025 (MT Newswires) -- Boeing's ( BA ) financial outlook over the coming years remains constrained as unit economics and working capital trends continue to be impacted in the near-medium term, Deutsche Bank said in a Thursday research note. The brokerage cuts its 2026 free cash flow guidance by 56% to $2.10 billion, 2027 guidance by 40%...